chimeric antigen receptor gene modified T cells Clinical Trials

2 actively recruiting trials

Also known as: CAR-T

Top Sponsors

Shanxi Bethune Hospital2

Indications

Cancer2
Lymphoma, B-Cell1
Acute Lymphocytic Leukemia1
Relapsed/ Refractory Multiple Myeloma1
Lymphoma, Non-Hodgkin1

Other2 trials

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

N/A

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.